US equities
|
INTC
$65.90
▼-28.43%
MU
$897.35
▼-3.95%
AMZN
$236.85
▼-2.85%
NVDA
$207.00
▼-3.11%
SNDK
$1,232.65
▼-7.32%
GOOGL
$281.47
▼-0.83%
AAPL
$344.81
▼-1.17%
AMD
$517.92
▼-8.56%
INTC
$65.90
▼-28.43%
MU
$897.35
▼-3.95%
AMZN
$236.85
▼-2.85%
NVDA
$207.00
▼-3.11%
SNDK
$1,232.65
▼-7.32%
GOOGL
$281.47
▼-0.83%
AAPL
$344.81
▼-1.17%
AMD
$517.92
▼-8.56%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Sana Biotechnology, Inc. - Common Stock
(NQ:
SANA
)
2.685
-0.035 (-1.29%)
Delayed Quote
Updated: 9:39 AM EDT, Oct 30, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Sana Biotechnology, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
Next >
SANA Deadline: Rosen Law Firm Urges Sana Biotechnology, Inc. (NASDAQ: SANA) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights
May 17, 2025
From
The Rosen Law Firm, P.A.
Via
Business Wire
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sana Biotechnology
May 14, 2025
From
Faruqi & Faruqi LLP
Via
GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Sana Biotechnology, Inc. and Certain Officers – SANA
May 13, 2025
From
Pomerantz LLP
Via
GlobeNewswire
Sana Biotechnology to Present at the BofA Securities 2025 Healthcare Conference
May 12, 2025
From
Sana Biotechnology, Inc
Via
GlobeNewswire
Faruqi & Faruqi Reminds Sana Biotechnology Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 20, 2025 - SANA
May 11, 2025
From
Faruqi & Faruqi LLP
Via
GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Sana Biotechnology, Inc. and Certain Officers – SANA
May 09, 2025
From
Pomerantz LLP
Via
GlobeNewswire
Sana Biotechnology Reports First Quarter 2025 Financial Results and Business Updates
May 08, 2025
From
Sana Biotechnology, Inc
Via
GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Sana Biotechnology, Inc. and Certain Officers – SANA
May 05, 2025
From
Pomerantz LLP
Via
GlobeNewswire
ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Sana Biotechnology, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SANA
April 30, 2025
From
The Rosen Law Firm PA
Via
GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Sana Biotechnology, Inc. and Certain Officers – SANA
April 29, 2025
From
Pomerantz LLP
Via
GlobeNewswire
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sana Biotechnology
April 26, 2025
From
Faruqi & Faruqi LLP
Via
GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Sana Biotechnology, Inc. and Certain Officers – SANA
April 25, 2025
From
Pomerantz LLP
Via
GlobeNewswire
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sana Biotechnology
April 23, 2025
From
Faruqi & Faruqi LLP
Via
GlobeNewswire
ROSEN, A RANKED AND LEADING FIRM, Encourages Sana Biotechnology, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SANA
April 21, 2025
From
The Rosen Law Firm PA
Via
GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Sana Biotechnology, Inc. and Certain Officers – SANA
April 21, 2025
From
Pomerantz LLP
Via
GlobeNewswire
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sana Biotechnology
April 20, 2025
From
Faruqi & Faruqi LLP
Via
GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Sana Biotechnology, Inc. and Certain Officers – SANA
April 17, 2025
From
Pomerantz LLP
Via
GlobeNewswire
SANA Investors Have the Opportunity to Lead the Sana Biotechnology Securities Fraud Lawsuit with Faruqi & Faruqi, LLP
April 16, 2025
From
Faruqi & Faruqi LLP
Via
GlobeNewswire
SANA Investors Have the Opportunity to Lead the Sana Biotechnology Securities Fraud Lawsuit with Faruqi & Faruqi, LLP
April 13, 2025
From
Faruqi & Faruqi LLP
Via
GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Sana Biotechnology, Inc. and Certain Officers – SANA
April 12, 2025
From
Pomerantz LLP
Via
GlobeNewswire
ROSEN, A LEADING AND RANKED FIRM, Encourages Sana Biotechnology, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SANA
April 09, 2025
From
The Rosen Law Firm PA
Via
GlobeNewswire
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sana Biotechnology
April 09, 2025
From
Faruqi & Faruqi LLP
Via
GlobeNewswire
SANA Stockholders Should Contact Shareholder Rights Law Firm Robbins LLP for Information on How to Lead the Class Action Against Sana Biotechnology, Inc.
April 07, 2025
From
Robbins LLP
Via
GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Sana Biotechnology, Inc. and Certain Officers – SANA
April 07, 2025
From
Pomerantz LLP
Via
GlobeNewswire
Faruqi & Faruqi Reminds Sana Biotechnology Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 20, 2025 - SANA
April 06, 2025
From
Faruqi & Faruqi LLP
Via
GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Sana Biotechnology, Inc. and Certain Officers – SANA
April 03, 2025
From
Pomerantz LLP
Via
GlobeNewswire
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Sana Biotechnology, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SANA
April 02, 2025
From
The Rosen Law Firm PA
Via
GlobeNewswire
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sana Biotechnology
April 02, 2025
From
Faruqi & Faruqi LLP
Via
GlobeNewswire
Cognyte Software Posts Upbeat Results, Joins AngioDynamics, Allegiant Travel And Other Big Stocks Moving Higher On Wednesday
↗
April 02, 2025
Via
Benzinga
Mineralys, Sana, Aeon: These 3 Biotech Stocks Saw The Sharpest Retail Interest Spike In Q1
↗
April 01, 2025
Three small-cap stocks have intrigued Stocktwits users the most among the biotech sector this year, thanks to promising data from clinical trials and a leadership shuffle.
Via
Stocktwits
< Previous
1
2
3
4
5
6
7
8
Next >
